Tracking the Initial Diffusion of SARS-CoV-2 Omicron Variant in Italy by RT-PCR and Comparison with Alpha and Delta Variants Spreading.
COVID-19
RT-PCR
SARS-CoV-2
VOC
molecular diagnosis
naso-oropharyngeal swabs
omicron variant
rapid screening
spreading
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
11 Feb 2022
11 Feb 2022
Historique:
received:
11
01
2022
revised:
08
02
2022
accepted:
10
02
2022
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
26
2
2022
Statut:
epublish
Résumé
The emergence of the Omicron SARS-CoV-2 variant caused public health concerns worldwide, raising the need for the improvement of rapid monitoring strategies. The present manuscript aimed at providing evidence of the utility of a diagnostic kit for the routine testing of SARS-CoV-2 infection as a cost-effective method for tracking the Omicron variant in Italy. The study was conducted on patients' naso-oropharyngeal-swab-derived RNA samples. These samples were subjected to RT-PCR using the TaqPath COVID-19 RT PCR CE IVD kit. Nonparametric testing and polynomial models fitting were used to compare the spreading of Alpha, Delta and Omicron variants. The samples of interest were correctly amplified and displayed the presence of S gene-target failure, suggesting that these patients carry the Omicron variant. The trend of diffusion was found to be significantly different and more rapid compared with that of the Alpha and Delta variants in our cohorts. Overall, these results highlight that the S gene target failure was a very useful tool for the immediate and inexpensive tracking of Omicron variant in the three weeks from the first detection. Thus, our approach could be used as a first-line screening to reduce the time and costs of monitoring strategies, facilitating the management of preventive and counteracting measures against COVID-19.
Identifiants
pubmed: 35204558
pii: diagnostics12020467
doi: 10.3390/diagnostics12020467
pmc: PMC8870788
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Nature. 2021 Dec;600(7887):21
pubmed: 34824381
Euro Surveill. 2021 Jan;26(3):
pubmed: 33478625
Pathogens. 2021 Nov 11;10(11):
pubmed: 34832619
J Intern Med. 2020 Aug;288(2):192-206
pubmed: 32348588
Am J Clin Pathol. 2022 Jan 06;:
pubmed: 34999740
J Med Virol. 2022 Jan 12;:
pubmed: 35023191
Behav Res Methods. 2020 Apr;52(2):464-488
pubmed: 31152384
J Pers Med. 2021 Sep 02;11(9):
pubmed: 34575659
J Clin Lab Anal. 2022 Jan;36(1):e24178
pubmed: 34921443
Int J Infect Dis. 2021 Jul;108:187-189
pubmed: 33878460
MedComm (2020). 2021 Dec 16;:
pubmed: 34957469
Front Immunol. 2021 Jun 23;12:708820
pubmed: 34249017